Evidence map›Paper›PMID 41809557›Full record

ArticleChemical science2026

Fully protected pyrophosphates

Sven Wijngaarden, Femke L A M van der Heijden, Koen J Rijpkema, Bob van Puffelen, Nico J Meeuwenoord, Danicia Ramcharan, Gijsbert A van der Marel, Jeroen D C Codée, Herman S Overkleeft, Dmitri V Filippov

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sven WijngaardenLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.
Femke L A M van der HeijdenLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.
Koen J RijpkemaLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.
Bob van PuffelenLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.
Nico J MeeuwenoordLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.
Danicia RamcharanLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.
Gijsbert A van der MarelLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.
Jeroen D C CodéeLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.ORCID https://orcid.org/0000-0003-3531-2138
Herman S OverkleeftLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.ORCID https://orcid.org/0000-0001-6976-7005
Dmitri V FilippovLeiden Institute of Chemistry, Leiden University Einsteinweg 55, 2333 CC Leiden The Netherlands filippov@chem.leidenuniv.nl.ORCID https://orcid.org/0000-0002-6978-7425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural oligomers containing phosphodiester linkages, such as DNA and RNA oligomers, are readily accessible through the phosphoramidite P(iii) approach. However, the repetitive introduction of pyrophosphates into an oligomeric backbone, as found in poly-ADP-ribose, remains challenging. The most effective method to date relies on P(iii)-P(v) coupling, in which a phosphate monoester is linked with a phosphoramidite, facilitating chain elongation of the biopolymer following the oxidation of the P(iii)-P(v) intermediate. This anionic and nucleophilic intermediate limits the chain length that can be achieved. To overcome this limitation, we designed a methodology based on P(v)-P(v) chemistry, where a phosphodiester is coupled to a protected and activated P(v) donor. To this end, the Atherton-Todd oxidation of H-phosphonates is utilised to generate an electrophilic halophosphate, which is then coupled with a phosphodiester to yield a fully protected pyrophosphate species. The chemistry was optimised to balance the reactivity and stability of the coupling partners and the product by introducing the

Identifiers

PMID41809557
PMCPMC12970391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.